Stocktoria

Asahi Kasei Corporation 3407.T

JP · Tokyo Stock Exchange · XTKS · stock · Industrials · website

Asahi Kasei Corporation (3407.T) earns a Piotroski F-score of 8/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.26% (safety: safe). FY2026 revenue was ¥3.07T at a 5.2% net margin.

Chart by TradingView
8/9
Piotroski F — financial health
4.21
Altman Z″ — distress risk · safe
34.2%
Dividend payout · safe
¥1,791.00 as of 2026-06-01 · +74.4% 1y
¥1,027.00¥1,844.5052-wk
Market cap USD$14.9B
P / E15.2×
Net margin5.2%
Beta0.65

Analyst price target

¥1,906.67 +6.5% vs last
consensus: buy · 12 analysts
range ¥1,400.00 – ¥2,300.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

About Asahi Kasei Corporation

Asahi Kasei Corporation engages in material, homes, and healthcare businesses in Japan, the United States, China, and internationally. The company offers Pimel, a photosensitive PI material applied for semiconductor applications, such as buffer coating, passivation layers, and dielectric layers; Sunfort, a dry film photoresist; Novacure, a latent curing agent for epoxy resin; glass fabric for printed circuit boards; plastic optical fiber; sensors and devices; artificial suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; alkaline water electrolyzer for producing hydrogen from renewable energy Aqualyzer; Hipore, a microporous polyolefin sheet which prevents the anode and cathode; Celgard, a lithium-ion battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, Bemliese, NanoAct, and ROICA names. It also provides cling film, bags, and containers under the Saran Wrap, Ziploc, and Cookper names; packaging products under the Suntec, Barrialon, PVDC latex, and Saran fiber names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company offers prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; virus removal filters; wearable defibrillators, temperature management systems, pre-hospital, and hospital data management systems; overseas homes, unit homes and apartment buildings, and real estate-related operations; autoclaved aerated concretes, foundation systems, thermal insulations, and structural systems and component products; polymers, monomers, foamed products, and cleaners; and synthetic rubber, elastomers, and intermediates and inorganic chemicals. Asahi Kasei Corporation was founded in 1922 and is headquartered in Chiyoda, Japan.

Revenue trend · last 4y · up

How it ranks in Industrials · percentile among 165 companies

Piotroski Fstronger than 76%
Net marginstronger than 34%
Return on equitystronger than 22%
Revenue growthstronger than 32%

Percentile vs other Industrials companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 8/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.259
Retained earnings / assets0.313
EBIT / assets0.056
Equity / liabilities1.059

FAQ

Is 3407.T financially healthy?

Asahi Kasei Corporation's Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does 3407.T pay a dividend, and is it safe?

Yes. Asahi Kasei Corporation pays a dividend yielding about 2.26% with a 34.2% payout ratio, rated “safe” for safety.

How profitable is 3407.T?

In FY2026, Asahi Kasei Corporation had a net margin of 5.2% and a return on equity of 7.6%.

Computed from company filings · JP · as of 2026-03-31. Figures in JPY. Facts plus Stocktoria's own computed scores — not investment advice.